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Abstract
Prebiotics, probiotics and synbiotics has been shown to enhance calcium 
absorption, gut and bone health. Probiotics are also known to ferment prebiotics to 
produce the fermentative substrates such as short chain fatty acids (SCFAs), mainly 
acetate, butyrate and propionate with the help of beneficial micro-organisms in the 
gut. The expression of these SCFAs has been associated with the inhibition of osteo-
clast differentiation and bone resorption both in vitro and in vivo. In this review, we 
discuss the benefits of SCFAs and ways in which prebiotics and probiotics affect 
bone health by the reduction of inflammation in the gut and the bone.
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1. Introduction
Prebiotics and probiotics have been proven to confer multiple health benefits 
to animals and humans alike when consumed either singly or in combination. 
Consumption of prebiotics and probiotics modulates the gut microbiota and the 
colonization of the gastrointestinal tract which is now known as the second gene 
pool of the human body. Evidence shows the health benefits of synbiotic intake in 
many aspects of human health including metabolic functions, gastrointestinal dis-
eases, and bone health. Some of these documented evidence-based benefits include 
their immunomodulatory effect [1], improvement of diarrhea, lactose metabolism, 
digestive health and metabolic syndrome [2], antidiabetic and hypocholestrolemic 
[3], anticarcinogenic [4] and hypotensive attributes/features [5]. In a short review 
that we conducted, the importance of prebiotics, probiotics and synbiotics was 
expressed to be important across human lifespan from childhood to adulthood and 
the elderly [6].
2. The significance of prebiotics and probiotics
Probiotics in the presence of prebiotics undergo different biochemical pathways/
messenger systems to inhibit pathogens and boost the immunity of the host, these 
includes
a. Presence of probiotics in the gut leads to competition for nutrients with 
pathogens which can then lead to starvation and reduction of these unwanted 
bacteria.
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b. Probiotics tend to compete for space via the adhesion effect to the mucosal lining 
by directly decreasing the adhesion of the pathogens and their toxins; this has 
been confirmed by in vitro studies demonstrating that probiotics possess lectin-
like adhesion properties capable of binding carbohydrates from the receptors of 
glycoconjugate of epithelial cell surface [7] which blocks pathogen binding to 
the epithelial cell surface. Some probiotic strains of the Lactobacillus genus have 
shown some features and ability to bind to the enterocyte surface in vitro [8].
c. Probiotics are responsible for the synthesis of bacteriocins such as lantibiotics 
(class I) and class II bacteriocins by the probiotics, and this mainly by lactic 
acid bacteria (LAB) can help prevent the growth, colonization, and establish-
ment of pathogens in the gut environments. These bacteriocins present a better 
activity on the pathogens than antibiotics due to their narrow-spectrum activ-
ity on foreign unwanted bacteria. Bacteriocins from Gram-positive bacteria are 
composed of membrane peptides capable of targeting and causing apoptosis of 
the cell membrane; however, most antibiotics inhibit enzymes and biosynthe-
sis pathway in cells such as DNA, RNA, protein and cell-wall synthesis [9].
Probiotic microorganisms may also be able to produce enzymes, such as lipase, 
esterase, and co-enzymes A, Q, NAD, and NADP [10]. Likewise, some of the 
by-products of probiotics’ metabolism may exhibit antibiotic properties and these 
include bacitracin, lactacin and acidophiline [11].
d. The bio-metabolization of prebiotics into lactate and short chain fatty acids 
(SCFAs) such as acetate, mainly produced by Bifidobacteria, Lactobacilli and 
Akkermansia muciniphilia through fermentation by probiotics has significant 
beneficial role to the health. Acetate is the most abundant in the human colon. 
Butyrate is produced by Faecalibacterium prausnitzii, Eubacterium rectale and 
Roseburia spp. and mainly by Lachnospiraceae and Ruminococcaceae and propi-
onate which is produced by Propionibacteria,, Firmicutes, Lachnospiraceae and 
Bacteroidetes [12]. The release of these SCFAs by the prebiotic fermentation 
reduces the intestinal pH level and also reduces the production of putrefactive 
compounds such as ammonia, phenol, as well as indole and branched-chain 
fatty acids (BCFAs) [13]. SCFA synthesis are mainly by anaerobic saccharolytic 
fermentation of carbohydrates that have not been digested or absorbed in the 
small intestine. Acetate is metabolized in the muscles, kidney, brain and heart, 
butyrate acts mainly in the colon while propionate and butyrate are cleared by 
the liver. SCFAs may also regulate fat and glucose metabolism as reported in 
rat adipocytes [14]. In chronic inflammatory diseases such as IBD, it has been 
shown that fecal butyrate levels are significantly reduced while high levels of 
lactic acid are observed [15].
The production of butyrate is mainly from complex carbohydrates through the 
pyruvate and acetyl-coenzyme A (CoA) pathway; however, it can also be produced 
from amino acids via the glutarate, 4-aminobutyrate and lysine pathways in the 
gut [13]. Butyrate acts epigenetically as histone deacetylase (HDAC) inhibitors and 
the research into HDAC may be capable of providing cancer chemoprevention and 
therapies [16]. There are different functions of butyrate in the colon; it is the main 
source of energy for colonocytes. Furthermore, butyrate has been documented to 
inhibit proinflammatory cytokines such as tumor necrosis α (TNF-α) in monocytes 
[17], interferon-α (IFN-α) and IL-2 in rat mesenteric lymph nodes [18], chemokine 
CXCL-8 (IL-8) in Caco-2 cells [19].
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e. Intake of prebiotics and probiotics has been linked to the development of 
immunomodulatory capacity by decreasing inflammation, antibody response 
and phagocytosis. Probiotics may be involved in the prevention of cytokine-
induced epithelial damage. Lactobacillus rhamnosus GG (LGG) promoted the 
survival and enrichment of epithelial cells by the activation of antiapoptotic 
and inhibition of proapoptopic pathways [20].
f. Probiotic and prebiotic intake results in the improvement of the epithelial 
barrier integrity by the secretion of mucin [21] and defensins [22] including 
antimicrobial proteins (AMPs). Probiotics enhance the mucosal integrity also 
by inducing cytoprotective substance production by enterocytes such as heat 
shock proteins [23]. In an in vitro study, Bifidobacterium infantis enhanced 
the intestinal mucosal barrier (T84 human epithelial cells) [24]. Similarly, 
Lactobacillus plantarum is responsible for acting on the tight junctions via 
increasing the expression of occludins and zonula occludens proteins [25].
g. Prebiotics and probiotics are capable of the stimulation and production of 
antioxidant-related enzymes, systemic hormones, and neurochemicals such as 
serotonin, gamma-aminobutyric acid (GABA) and cortisol, as well as produc-
tion of bile salt hydrolase. Consumption of probiotics and prebiotics has also 
been reported to be able to reduce cholesterol levels. Prebiotic fibers increased 
levels of satiety hormones (glucagon-like peptide-1, proglucagon and peptide 
YY mRNA) and decreased levels of ghrelin O-acyltransferase mRNA in rats 
[26]. Furthermore, prebiotic fermentation in the gut likewise improved sati-
etogenic and incretin gut peptide production, thereby increasing the plasma 
glucagon-like peptide 1 and peptide YY concentrations in humans [27].
h. Prebiotics and probiotics are responsible for the synthesis of antigens via 
production of anti-inflammatory cytokine such as IL-10 which inhibits the 
T-helper cells (1, 2, 7 and 17) and transforming growth factor-β responsible for 
the production of immunoglobulin A [28].
The concept and use of prebiotics has been argued to be more important when 
compared to probiotics due to the vulnerability and susceptibility of probiotics 
to environmental stresses, manufacturing process (such as heat) and endangered 
conditions during storage [29].
3. Prebiotics and human health
Glenn Gibson and Marcel Roberfroid launched the prebiotic concept in 1995 
as ‘a nondigestible food ingredient that beneficially affects the host by selectively 
stimulating the growth and/or activity of one or a limited number of bacteria in the 
colon, and thus improves host health’ [30]. This definition has however been modi-
fied several times, but the initial main features have been retained. Prebiotics tend to 
stimulate the growth of the gut bacteria endogenously. The pH of the gut environ-
ment plays a major role in determining bacterial interspecies competition outcome.
Food sources of prebiotics consist of edible plants such as fruits, vegetables, 
cereal component which provides the body with carbohydrate. Specific potential 
sources are artichokes, tomatoes, bananas, asparagus, garlic, berries, kiwi fruit, 
onions, chicory, green leafy vegetables, legumes as well as linseed, barley, oats, 
and wheat.
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Even though various molecules can be prebiotics, the great majority are dietary 
fibers which are oligosaccharides such as inulin (mainly from chicory), GOS 
(obtained from lactose using β-galactosidase), Fructooligosaccharides (FOS) (from 
chicory by partial enzymatic hydrolysis), soybean oligosaccharides (SOS), and 
xylooligosaccharides (XOS). Inulin, GOS and FOS have been widely studied. The 
list of prebiotics also includes compounds such as resistant starches, arabinoxylan, 
pectin, whole grains as well as non-carbohydrate complex such as polyphenols 
[13]. Absence of dietary fiber in the colon causes anaerobic bacteria to obtain their 
energy from protein fermentation, and this metabolism leads to the production of 
potentially toxic and carcinogenic compounds such as ammoniac and phenolic com-
pounds [31]. In contrast, carbohydrate fermentation (for example dietary fiber) 
will produce non-toxic SCFAs which can serve as fuel for the epithelial cells. The 
production of volatile fatty acids, including, SCFAs and BCFAs, play a role in energy 
homeostasis maintenance as well as in the regulation of functionality in peripheral 
tissues [32]. Prebiotics are also mainly active in the large intestine/colon.
Different strains of bacterial genus or species would prefer different substrates 
for fermentation in the colon. Generally, the strains of Bifidobacterium and 
Lactobacillus genera have been reported to prefer fructans as substrate, as opposed 
to glucose while other bacteria such as Clostridia and Bacteroides have been reported 
to thrive on fructans [33, 34].
The use of prebiotics has been shown to be efficient and effective against a few 
human health disorders such as Type 2 diabetes mellitus and inflammatory bowel 
diseases which has been termed the “Western” chronic diseases and colorectal can-
cer. This is accomplished by the modulation of the intestinal gut microbiota which 
confer a protective, metabolic, and trophic benefits to the host [13].
4. Probiotics and human health
The history of probiotics spans back to the 20th century when Mechnicoff 
(1907) revealed the virtues associated with the consumption of fermented dairy 
products, he hypothesized that the aging process resulted from the putrefaction of 
the large intestine. Almost simultaneously, another scientist Tissier indicated that 
the main component of the gut flora of breast-fed infants were bifidobacterial [35]. 
Even earlier, biblical recommendations have pointed out yoghurt as important/
significant for the treatment of some ailments [36]. Furthermore, the indication 
has been that probiotics is more beneficial when consumed with food as opposed to 
supplement due to the available nutrient and energy sources. Probiotics are mainly 
active in the small and large intestine.
Organizations such as FAO, WHO and the European Food Safety Authority have 
indicated probiotic strains must meet both safety and effectiveness criteria for their 
selection process. The regulations require that safety and absence of risks is para-
mount for human and animal health. The human probiotic products usually belong 
to the Lactobacillus, Bifidobacterium, Lactococus, Streptococcus and Enterococcus 
genus. In addition, there are some Gram-positive bacteria of genus Bacillus and 
some yeast of Saccharomyces genus which are also used as probiotics.
Probiotic use has been postulated to be potent against human disorders such 
as inflammatory enteral diseases such as Crohn’s disease, colitis, and non-specific 
ileitis. Intake of probiotics has also been assessed by various studies as capable of 
treating lactose intolerance, irritable bowel syndrome [37] and in the prevention of 
peptic ulcers and colorectal cancer [38]. Beneficial effects of probiotics have been 
observed in the process of digestion, food allergies treatment [39], dental caries 
[40], and candidoses [41]. The beneficial effects of probiotics observed by the host 
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through augmentation of the epithelial wall, intestinal mucosal and competitive 
elimination of pathogens has been reported to aid inflammatory bowel disease 
(determined by cytokine-induced harm to the epithelial cell walls). Probiotics 
is capable of repressing gut inflammation via the downregulation of Toll-like 
Receptors’ expression, the prevention of TNF-α entrance into the mononuclear cell 
in blood and the suppression of enterocyte’s NF-kB (Nuclear Factor kappa-light-
chain-enhancer of activated B cells) signaling pathway [42].
5. Synbiotics and human health
Synbiotics are a combination of prebiotics and probiotics. The consumption and 
intake of the combination of prebiotics and probiotics has been reported to stimu-
late, modulate, and alter the gut microbiota by lowering the colonic secretion of 
pro-inflammatory and immunoregulatory cytokines such as TNF-α, IL-1β and IL-6. 
Synbiotics can be used to help improve the beneficial microbes as well as increase 
the number of specific beneficial strains in the gastrointestinal tract [11].
Immunomodulatory effects of prebiotics and probiotics on human health.
One the putative ways by which prebiotics and probiotics affect the health 
is altering the immune system. There are two categories of the immune system: 
either the innate immunity or the adaptive immune system. The immune system is 
responsible for protecting the host against pathogens. The type of effective immune 
response which recognizes and mounts reactions to eliminate the pathogen is deter-
mined by the site and type of pathogen present. Prebiotics and probiotics modulate 
the gut immune system thereby also having effects on bone health.
Further studies are needed to investigate the benefits of synbiotics on bone 
health both in human and animal model.
6. Probiotics and bone health
Bone loss/osteoporosis is a major health problem that is associated with the 
imbalance between bone formation and bone resorption; often resulting in osteo-
porotic fractures. In addition, the estimation is that one in two women and one in 
four men over the age of 50 years will break a bone due to osteoporosis in their life 
time [43]. Postmenopausal osteoporosis is largely attributed to estrogen deficiency 
in women age 50 years and above due to ablation of the ovarian function which 
stimulates bone resorption resulting in bone loss. Risk factors leading to bone 
diseases include internal (genetic and aging) and external modifiable factors (e.g., 
diet, exercise, environment, medication etc). In osteoporosis treatment, different 
approaches have been used but lately due to the safety, low adverse effect and lack 
of major side effects, probiotics and prebiotics have been introduced. Treatment 
of bone diseases including osteoporosis and fracture has been mainly through 
hormone replacement therapy (HRT) as well as others such as bisphosphonates 
and more recently low-dose parathyroid hormone. However, there are side effects 
reported with this such as tumorigenesis, mood swings, fluid retention and bleed-
ing as well as low compliance of daily injections [44].
7. The role probiotics in inflammatory homeostasis
Probiotics may aid the modulation of the hosts’ inflammatory status by reducing 
the cytokine secretion levels. The downregulation of proinflammatory cytokines 
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such as IL-6 [45] and TNF-α [46, 47] by probiotics has been reported on several 
occasions. Studies have shown that some peptides such as p40 and p75 secreted 
by Lactobaccillus rhamnosus GG (LGG) may prevent cytokine-induced apoptosis, 
increase heat-shock proteins, and could lead to the activation of mitogen-activated 
protein kinase (MAPK) [48]. Furthermore, TNF (as well as IL-1 and RANKL) 
has been described as the major physiological inducer of NF-kappa B, one of the 
transcription factors responsible for the regulation of normal cell functions and the 
development of inflammatory osteolysis [49].
The role of the intestinal microbiota has been implicated in influencing bone 
health. A way by which the intestinal tract aids bone is by the regulation of the 
absorption of minerals such as calcium, phosphorus, and magnesium. This can also 
be accomplished by endocrine and gut-derived factors such as incretins and sero-
tonins which may influence bone remodeling. Evidence from using germ-free mice 
indicated the effect of the intestinal microbiome on bone physiology. These studies 
observed higher bone mass in germ-free mice as compared to the conventional 
mice. In addition, a decrease in the number of osteoclasts per bone surface and a 
reduction in CD4+ T cells and osteoclasts precursors were observed in the bone 
marrow of the mice [50].
The RANKL/RANK/OPG pathway is one of the mechanisms that influence 
bone turnover/remodeling. Osteoclast’s formation and activities are controlled by 
the RANKL/RANK pathway. They are also an essential pathological process of the 
bone remodeling. Concomitantly, OPG (decoy receptor of RANKL) acts as a bone 
protector by binding to RANKL and preventing further resorption [42]. Probiotics 
(beneficial microbes) have been postulated to reduce inflammation [51] and 
increase OPG expression in bone [52].
8. Studies emphasizing the importance of probiotics for bone health
8.1 Animal studies
Studies have shown that various strains of Lactobacillus [52–54] and 
Bifidobacterium [55, 56] possess the ability to prevent and restore estrogen 
deficiency-related bone loss in animal models. However, not many studies have 
been conducted in humans. The study by Ohlsson et al. showed that C-terminal 
telopeptides (resorption markers) levels were not increased in probiotic treated 
mice as compared to the vehicle treated mice. Furthermore, there was a reduction in 
expression of two proinflammatory cytokines (TNF-α and IL-1β), and an increase 
in the expression of OPG in the cortical bone of ovariectomised mice [52].
Lactobacillus reuteri ATCC PTA 6475 has been used in two animal studies to 
modulate bone outcomes. Findings from the first study showed increase in femoral 
trabecular BV/TV, BMD, BMC, trabecular number, spacing, and thickness as well 
as suppression of the basal TNF-α mRNA expression in the ileum and jejunum in 
14-week-old C57Bl/6 J male mice [51]. Meanwhile, the second study showed similar 
positive bone effects in Ovx Balb/c mice when treated with Lactobacillus reuteri for 
four weeks and changes in the gut microbiota composition was observed revealing 
an increase in Clostridiales and a decrease in Bacteroidales in the ileum and jejunum 
[57]. Furthermore, a study by Collins et al. showed that supplementation with 
Lactobaccillus reuteri 6475 could influence inflammatory status and bone formation 
after the inflammatory state of female mice were mildly induced. This was achieved 
via a dorsal surgical incision (DSI) and then administration of the probiotic. The 
findings indicated that the probiotic supplementation increased bone density, the 
DSI-treated female mice showed higher trabecular number and mineral apposition 
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rate when compared to the non-treated mice. Although L. reuteri treatment had no 
effect on CD4+ T cell numbers, it led to a decrease in IL-1β and TGFβ expression in 
the non-surgery cohort [58].
Probiotics are known to aid mineral absorption for the purpose of bone health 
maintenance. A study showed that supplementation of growing rats with L. 
rhamnosus HN001 enhanced calcium and magnesium absorption [59]. In addition, 
rats treated with yoghurt with a mix of Lactobacillus casei, L. reuteri and L. gas-
seri presented higher calcium absorption which resulted in an increased BMC in 
comparison to the control as well as production of SCFAs [60].
Narva et al. demonstrated the effect a bioactive peptide (valylprolyl-proline) 
and Lactobacillus helveticus LBK-16H fermented milk on bone loss in ovariecto-
mized rats. Their findings showed that L. helveticus fermented milk decreased bone 
turnover and increased BMD in growing rats [61], ovariectomised rats [62] and 
increased serum calcium while reduced serum PTH was observed in postmeno-
pausal women [63].
Studies have also shown that supplementation with Bifidobacterium longum-fer-
mented broccoli suppressed TRAP-positive osteoclast differentiation on the alveolar 
bone surface in rats [64]. Similarly, administration of yacon flour as prebiotics with 
B. longum as probiotics resulted in significant retention of minerals (such as Ca, Mg 
and P) in bones of Wistar rats [56]. B. longum also increased the BMD of ovariect-
omised rats by increasing the expression of Sparc and Bmp-2 genes [55].
In a study, male senescence-accelerated mice prone to developing osteoporosis 
with aging were orally administered heat-killed and living (viable) Lactococcus lactis 
subsp. cremoris H61 (strain H61). The protective effect of the heat-killed bacterium 
included reduction in loss of bone density, reduction in incidence of skin ulcer and 
reduction in hair loss of the aged SAMP6 [65]. On the other hand, reduction of bone 
density loss was not observed for the administration of the viable bacterium which 
may suggest the role of membrane-bound protein, inactivated microbial cells or cell 
fractions from the cellular death, that is, paraprobiotic and/or postbiotic effect.
The growth of bone as an extra-intestinal organ is suppressed by undernutrition 
in children. The study by Schwarzer et al. indicated that L. plantarum promoted 
juvenile growth in a strain-dependent manner using mono-colonized mouse model 
[66]. Supplementation with the bacterium increased the levels of insulin growth 
factor (IGF-1) and IGF-1 binding protein-3 (IGFBP- 3), the endocrine determi-
nants of somatic growth to wild type levels [66].
Furthermore, the effects of probiotics have also been reported in dysbiosis-
induced bone loss observed in the periodontal model [67, 68], Type-1 diabetes-
induced bone loss [69] and IBD-induced bone loss [70, 71].
8.2 Human studies
A human study conducted in Denmark evaluated the combined effects of 
bioavailable isoflavones and probiotics on bone health and estrogen metabolism 
using a randomized controlled trial in postmenopausal women. Their findings 
showed that administration red clover extract (isoflavones) and probiotic attenu-
ated BMD at the lumbar spine and femoral neck, reduced plasma concentrations of 
C-terminal telopeptide of type I collagen (CTX-1) as well as increased the urinary 
2-hydroxyestrone (2-OH) to 16α-hydroxyestrone (16α-OH) ratio (the equol pro-
ducer status) [72].
The use of probiotics however needs to be administered with caution since 
although the potential beneficial effect in the treatment of inflammatory and 
auto-immune gastrointestinal diseases for the modulation of immune response is 
well recognized, individuals with weaker immune systems may still be at risk of 
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viable bacterial cells; in which case the administration the use of killed/inactivated 
bacteria might be more beneficial [73].
9. Prebiotics and bone health
Prebiotics are non-digestible short-chain carbohydrates also known as oligosac-
charides (and maybe polysaccharides) which selectively improves the function and 
activities of specific types of beneficial microbes. The chemical compounds are 
neither hydrolyzed by the human digestive system nor absorbed in the upper gas-
trointestinal tract. Prebiotics have been termed ‘colonic foods’ due to the ability of 
these types of foods to move through the colon serving as a substrate to endogenous 
bacteria while benefitting the host by providing energy and essential nutrients [74].
9.1 Animal studies
Some varieties of benefits have been attributed to the consumption of prebiotics. 
These include the ability of prebiotics to increase the absorption of minerals such 
as calcium, magnesium, and phosphorus [75–78] as well as iron [79] as reported 
quite recently. The absorption of these minerals has consequently been observed to 
improve bone mineralization and density [80], trabecular structure and increase 
equol production [81] which is known to reduce bone loss.
9.2 Human studies
FOS supplementation has been administered to both Korean [82] and Chinese 
[83] postmenopausal women to investigate its effect in the prevention of osteoporo-
sis, modulation of bone biomarkers and mineral absorption. Their findings indicate 
that there is potential for prebiotics to play a pivotal role in the above mentioned. 
The study by van den Heuvel et al. reported the benefit of intake of both GOS and 
inulin in increasing calcium absorption in postmenopausal women [84] and oligo-
fructose stimulating calcium absorption in adolescents [85]. Intake of oligofructose-
enriched inulin resulted in improved mineral absorption and impacted the bone 
turnover markers in postmenopausal women [86]. Other studies also looked into 
the effect of prebiotics in infants as was recorded with GOS, polydextrose [87] and 
inulin [88]. Some of these studies have also been conducted in animal models as has 
been shown in a recent review [89].
10. Other clinical benefits of prebiotics
Due to the effect of the change in metabolism from protein fermentation caus-
ing the release of ammonia that leads to an increase in pH to more carbohydrate 
fermentation resulting in the release of acids, a reduction in the intestinal pH is 
observed. Low intestinal pH tends to increase bowel movement while protecting 
against pathogens. Diseases such as inflammatory bowel disease (IBD), irritable 
bowel syndrome (IBS) and Crohn’s diseases are characterized by high pH levels 
[90]. Prebiotics are therefore able to reduce the symptoms and severity of these 
diseases. In addition, they are able to restore intestinal bacterial imbalance created 
by antibiotics, diarrhea, stress and sometimes medication and drugs intake [74].
Prebiotics are also known to help relief constipation. Most carbohydrates are 
able to increase water retention of the intestine and the acids’ production thereby 
increasing intestinal motility [91]. Furthermore, prebiotics have been used as 
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bioactive functional foods to modulate blood lipid levels [92] and it also been 
effective in weight loss and metabolic syndrome [93]. The anti-carcinogenic effects 
of both prebiotics and probiotics have been reported in the inhibition of aberrant 
crypt foci (ACF) which is a biomarker of colon cancer [94–96].
Recently, prebiotic food and Bidobacterium spp. have been reported to improve 
bone resorption and reduce serum TRACP-5b levels of Japanese female athletes 
[97]. Application of the combination of probiotic and prebiotic has been reported 
to confer a synergistical effect on the host due to the combined benefits of the two. 
This has been backed with the study by Scholz-Ahrens et al. which showed that 
probiotics supports the growth of other habitual microbiota strains and prebiotics 
chain length impacts the composition colonic, caecal, and fecal microflora. The 
combined administration of oligofructose and Lactobacillus acidophilus reduced the 
pH in the intestinal segments including the caecum, stimulated the colonic absorp-
tion as is indicated by increase in the colon weight [98].
11. Conclusion
The study of the effect of synbiotics on gut microbiota and bone health profile 
is now growing rapidly. Probiotic strains have differing genotype and phenotype 
and may therefore show different metabolic and immunological functions. The 
mechanisms however still need further investigation to look into the effect of synbi-
otics on the gut for the regulation of bone metabolism via the process of mineral 
absorption, the immune, endocrine system. Further studies are needed to elucidate 
the importance and mechanisms by which prebiotics and probiotics modulates the 
microbiota-gut-bone axis in order to get the full benefit of the long-term safety and 
efficacy of consumption of these functional bioactive products.
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